Innospec Historical Income Statement

IOSP Stock

USD 118.61 0.95 0.81%

Historical analysis of Innospec income statement accounts such as Selling General Administrative of 401.2 M or Total Revenue of 2 B can show how well Innospec performed in making a profits. Evaluating Innospec income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Innospec's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Innospec latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Innospec is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

About Innospec Income Statement Analysis

Innospec Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Innospec shareholders. The income statement also shows Innospec investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Innospec Income Statement Chart

At this time, Innospec's Net Income is relatively stable compared to the past year. As of 11/30/2024, Net Income Applicable To Common Shares is likely to grow to about 160.6 M, while Operating Income is likely to drop slightly above 97.1 M.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Income Before Tax

Total Revenue

Total revenue comprises all receipts Innospec generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Innospec minus its cost of goods sold. It is profit before Innospec operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Innospec. It is also known as Innospec overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Innospec income statement and is an important metric when analyzing Innospec profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Innospec's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.At this time, Innospec's Net Income is relatively stable compared to the past year. As of 11/30/2024, Net Income Applicable To Common Shares is likely to grow to about 160.6 M, while Operating Income is likely to drop slightly above 97.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	434.9M	586.7M	591.1M	319.1M
Total Revenue	1.5B	2.0B	1.9B	2.0B

Gross Profit Total Revenue

Innospec income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Extraordinary Items	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.12	0.17	0.26	0.49	0.24	0.56	0.47	0.28	0.7	0.23	0.28	0.37	-0.21	0.06	0.61	0.47	0.68	-0.18	0.35	0.37	0.19	0.24	-0.22	-0.14
Interest Expense	0.12		0.16	0.2	0.13	0.21	0.01	0.22	0.27	0.23	0.21	0.19	0.09	0.19	-0.01	0.39	-0.41	-0.29	-0.04	-0.18	0.21	0.5	-0.16	-0.69	0.23
Selling General Administrative	0.17	0.16		0.97	0.76	0.98	0.4	0.37	0.74	0.39	0.97	0.99	0.42	0.08	0.71	0.24	-0.45	0.39	0.49	0.85	-0.5	0.4	0.48	0.48	-0.88
Total Revenue	0.26	0.2	0.97		0.81	1.0	0.49	0.51	0.75	0.53	1.0	0.98	0.5	0.03	0.71	0.39	-0.37	0.48	0.51	0.84	-0.45	0.53	0.42	0.38	-0.87
Gross Profit	0.49	0.13	0.76	0.81		0.8	0.78	0.66	0.88	0.68	0.8	0.79	0.78	0.02	0.59	0.57	-0.23	0.46	0.54	0.66	-0.32	0.52	0.43	0.16	-0.6
Other Operating Expenses	0.24	0.21	0.98	1.0	0.8		0.46	0.47	0.76	0.49	1.0	0.98	0.47	0.01	0.69	0.36	-0.4	0.47	0.5	0.84	-0.44	0.51	0.42	0.39	-0.86
Operating Income	0.56	0.01	0.4	0.49	0.78	0.46		0.83	0.5	0.84	0.45	0.45	0.95	0.32	0.65	0.76	0.15	0.41	0.65	0.34	-0.37	0.51	0.16	0.03	-0.32
Ebit	0.47	0.22	0.37	0.51	0.66	0.47	0.83		0.39	0.96	0.47	0.45	0.88	0.38	0.68	0.82	0.17	0.41	0.6	0.26	-0.33	0.73	0.12	-0.09	-0.32
Research Development	0.28	0.27	0.74	0.75	0.88	0.76	0.5	0.39		0.4	0.77	0.73	0.54	-0.1	0.37	0.35	-0.6	0.2	0.45	0.62	-0.23	0.37	0.43	0.07	-0.48
Ebitda	0.7	0.23	0.39	0.53	0.68	0.49	0.84	0.96	0.4		0.48	0.49	0.82	0.24	0.59	0.85	0.29	0.57	0.43	0.36	-0.16	0.65	0.18	-0.11	-0.35
Cost Of Revenue	0.23	0.21	0.97	1.0	0.8	1.0	0.45	0.47	0.77	0.48		0.97	0.47	-0.01	0.68	0.37	-0.41	0.46	0.5	0.83	-0.43	0.52	0.4	0.37	-0.86
Total Operating Expenses	0.28	0.19	0.99	0.98	0.79	0.98	0.45	0.45	0.73	0.49	0.97		0.46	0.08	0.72	0.32	-0.36	0.47	0.47	0.85	-0.45	0.45	0.5	0.43	-0.88
Income Before Tax	0.37	0.09	0.42	0.5	0.78	0.47	0.95	0.88	0.54	0.82	0.47	0.46		0.46	0.72	0.73	0.0	0.25	0.75	0.27	-0.46	0.62	0.15	0.01	-0.3
Total Other Income Expense Net	-0.21	0.19	0.08	0.03	0.02	0.01	0.32	0.38	-0.1	0.24	-0.01	0.08	0.46		0.59	0.17	-0.07	-0.3	0.5	-0.19	-0.44	0.29	-0.12	0.06	0.0
Net Income	0.06	-0.01	0.71	0.71	0.59	0.69	0.65	0.68	0.37	0.59	0.68	0.72	0.72	0.59		0.34	-0.14	0.31	0.81	0.54	-0.74	0.44	0.33	0.48	-0.68
Income Tax Expense	0.61	0.39	0.24	0.39	0.57	0.36	0.76	0.82	0.35	0.85	0.37	0.32	0.73	0.17	0.34		0.2	0.3	0.32	0.12	-0.08	0.8	-0.13	-0.39	-0.14
Minority Interest	0.47	-0.41	-0.45	-0.37	-0.23	-0.4	0.15	0.17	-0.6	0.29	-0.41	-0.36	0.0	-0.07	-0.14	0.2		0.52	-0.34	-0.17	0.32	-0.07	-0.17	-0.01	0.13
Extraordinary Items	0.68	-0.29	0.39	0.48	0.46	0.47	0.41	0.41	0.2	0.57	0.46	0.47	0.25	-0.3	0.31	0.3	0.52		0.02	0.66	0.07	0.1	0.39	0.34	-0.59
Net Income From Continuing Ops	-0.18	-0.04	0.49	0.51	0.54	0.5	0.65	0.6	0.45	0.43	0.5	0.47	0.75	0.5	0.81	0.32	-0.34	0.02		0.31	-0.84	0.38	0.22	0.3	-0.41
Non Recurring	0.35	-0.18	0.85	0.84	0.66	0.84	0.34	0.26	0.62	0.36	0.83	0.85	0.27	-0.19	0.54	0.12	-0.17	0.66	0.31		-0.28	0.13	0.48	0.62	-0.89
Non Operating Income Net Other	0.37	0.21	-0.5	-0.45	-0.32	-0.44	-0.37	-0.33	-0.23	-0.16	-0.43	-0.45	-0.46	-0.44	-0.74	-0.08	0.32	0.07	-0.84	-0.28		-0.18	-0.32	-0.56	0.52
Tax Provision	0.19	0.5	0.4	0.53	0.52	0.51	0.51	0.73	0.37	0.65	0.52	0.45	0.62	0.29	0.44	0.8	-0.07	0.1	0.38	0.13	-0.18		-0.27	-0.26	-0.29
Interest Income	0.24	-0.16	0.48	0.42	0.43	0.42	0.16	0.12	0.43	0.18	0.4	0.5	0.15	-0.12	0.33	-0.13	-0.17	0.39	0.22	0.48	-0.32	-0.27		0.39	-0.42
Net Interest Income	-0.22	-0.69	0.48	0.38	0.16	0.39	0.03	-0.09	0.07	-0.11	0.37	0.43	0.01	0.06	0.48	-0.39	-0.01	0.34	0.3	0.62	-0.56	-0.26	0.39		-0.75
Reconciled Depreciation	-0.14	0.23	-0.88	-0.87	-0.6	-0.86	-0.32	-0.32	-0.48	-0.35	-0.86	-0.88	-0.3	0.0	-0.68	-0.14	0.13	-0.59	-0.41	-0.89	0.52	-0.29	-0.42	-0.75

Click cells to compare fundamentals

Innospec Account Relationship Matchups

Innospec income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	52.9M	50.7M	46.2M	45M	39.3M	30.9M
Interest Expense	8.2M	6.9M	4.8M	1.5M	1.1M	4.0M
Selling General Administrative	261.3M	237M	267.2M	360.7M	382.1M	401.2M
Total Revenue	1.5B	1.2B	1.5B	2.0B	1.9B	2.0B
Gross Profit	466.2M	342.7M	434.9M	586.7M	591.1M	319.1M
Other Operating Expenses	1.4B	1.1B	1.4B	1.8B	1.8B	1.9B
Operating Income	149.9M	82.6M	132.1M	187.3M	161.6M	97.1M
Ebit	149.9M	41.5M	135.9M	142.3M	161.6M	117.6M
Research Development	35.4M	30.9M	37.4M	38.7M	41.7M	21.3M
Ebitda	202.8M	92.2M	182.1M	187.3M	200.9M	160.1M
Cost Of Revenue	1.0B	850.4M	1.0B	1.4B	1.4B	1.4B
Total Operating Expenses	316.3M	267.9M	304.6M	399.4M	429.5M	451.0M
Income Before Tax	150.4M	39.7M	134.4M	184.6M	174.4M	87.2M
Total Other Income Expense Net	500K	(35.1M)	2.3M	(2.7M)	12.8M	13.4M
Net Income	112.2M	28.7M	93.1M	133M	139.1M	146.1M
Income Tax Expense	38.2M	11M	41.3M	51.6M	35.3M	27.6M
Net Income Applicable To Common Shares	112.2M	28.7M	93.1M	133M	153.0M	160.6M
Net Income From Continuing Ops	112.2M	28.7M	93.1M	133M	126.8M	99.4M
Non Operating Income Net Other	5.3M	7.8M	3.8M	(1.6M)	(1.4M)	(1.4M)
Tax Provision	38.2M	11M	41.3M	51.6M	47.5M	43.6M
Net Interest Income	(4.8M)	(1.8M)	(1.5M)	(1.1M)	800K	840K
Reconciled Depreciation	47.6M	46M	42.7M	40.1M	38.3M	36.0M

Pair Trading with Innospec

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.

Moving together with Innospec Stock

0.68	CC	Chemours	Pair Corr
0.82	ECVT	Ecovyst Potential Growth	Pair Corr

Moving against Innospec Stock

0.61	ASH	Ashland Global Holdings	Pair Corr
0.57	DNMR	Danimer Scientific	Pair Corr
0.4	FF	FutureFuel Corp	Pair Corr
0.33	FEAM	5E Advanced Materials	Pair Corr

The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.

The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innospec Historical Income Statement

About Innospec Income Statement Analysis

Innospec Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Income Before Tax

Innospec income statement Correlations

Innospec Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Innospec income statement Accounts

Pair Trading with Innospec

Moving together with Innospec Stock

Moving against Innospec Stock

Additional Tools for Innospec Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 0.99	Selling General Administrative
Other Operating Expenses	+ 0.98	Selling General Administrative
Total Operating Expenses	+ 0.98	Total Revenue

Reconciled Depreciation	- 0.89	Non Recurring
Reconciled Depreciation	- 0.88	Total Operating Expenses
Reconciled Depreciation	- 0.88	Selling General Administrative
Reconciled Depreciation	- 0.87	Total Revenue
Reconciled Depreciation	- 0.86	Cost Of Revenue
Reconciled Depreciation	- 0.86	Other Operating Expenses